{
    "2021-11-03": [
        [
            {
                "time": "",
                "original_text": "另眼看待季报系列之三：固收+基金都在配什么？",
                "features": {
                    "keywords": [
                        "固收+",
                        "基金",
                        "配置"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业一周观察：三季报后板块表现分化 关注估值合理的优质标的",
                "features": {
                    "keywords": [
                        "医药",
                        "三季报",
                        "板块分化",
                        "估值合理",
                        "优质标的"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德被传“变相降薪”，回应称还在讨论，CRO行业要“入冬”了？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "变相降薪",
                        "CRO行业",
                        "入冬"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "Wellington Management Group LLP增持药明康德股份约34.52万股",
                "features": {
                    "keywords": [
                        "Wellington Management",
                        "增持",
                        "药明康德"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "公募基金持股市值创新高，社保显著加仓周期股（附表）",
                "features": {
                    "keywords": [
                        "公募基金",
                        "持股市值",
                        "创新高",
                        "社保",
                        "加仓",
                        "周期股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "周期"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "农业拉升电新杀跌，强势板块回调市场见底？",
                "features": {
                    "keywords": [
                        "农业",
                        "拉升",
                        "电新",
                        "杀跌",
                        "强势板块",
                        "回调",
                        "见底"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "农业",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "上市不过3年，百亿利润到手，药明康德的钱都是哪来的？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "上市",
                        "利润",
                        "来源"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "海通证券：予药明康德(603259.SH)“优于大市”评级 价值区间175.95-186.3元",
                "features": {
                    "keywords": [
                        "海通证券",
                        "药明康德",
                        "评级",
                        "优于大市",
                        "价值区间"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "从三季报和高频探测模型看基金抱团最新变化",
                "features": {
                    "keywords": [
                        "三季报",
                        "高频探测模型",
                        "基金抱团",
                        "变化"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}